- Market Access, alongside Medical Affairs, is a crucial skill-set in operating a successful rare disease/oncology asset in Russia and the CIS markets. Generally speaking there are three types of Regional funding and one type of National funding. Our team has the skill-set and knowledge to achieve success in any pathway, both pre and post licensure
- Identifying and delivering critical therapeutic value proposition of our products in treating targeted disease conditions.
- Assessing opportunities to develop access strategies for maximizing patients’ access for the products: regulatory, pricing, reimbursement/inclusion plans.
- Understanding access environment and needs of stakeholders involved in the adoption, positioning and funding of the products.
- Supporting payers’ disease awareness and education.
- Maintaining appropriate positioning for all our products.
